Is Boston Scientific A Smart Long-Term Buy?

96
7
Favorite

Is Boston Scientific A Smart Long-Term Buy?

Insider Monkey2021-09-23

Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

SPOT_ON
·2021-09-24
Like n follow
Reply
1
Report
FlareSpark
·2021-09-24
Robot is the future
Reply
2
Report
SSSG
·2021-09-23
Thanks for the info
Reply
1
Report
ParrySKLow
·2021-09-23
Thanks for sharing
Reply
2
Report
Fold Replies
- MachineGun:
  Yep
  2021-09-23
  Reply
  Report
Zarkness
·2021-09-23
Hi ??
Reply
2
Report
ac1887
·2021-09-23
Good
Reply
7
Report
Fold Replies
- Foreverhuat:
  Good
  2021-09-23
  Reply
  Report
KHYAP
·2021-09-23
????????
Reply
5
Report
Fold Replies
- ac1887:
  Good
  2021-09-23
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2169666103?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-23 17:09","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2169666103","market":"us","top_or_hot":-1,"title":"Is Boston Scientific A Smart Long-Term Buy?","media":"Insider Monkey","content":"<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","article_id":"2169666103","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","pubTimestamp":1632388163,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"波士顿科学是一个明智的长期购买吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":0.9},"content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":863704569,"gmtCreate":1632432811451,"gmtModify":1676530779350,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"idStr":"3582922989777578","authorIdStr":"3582922989777578"},"htmlText":"Like n follow&nbsp;","listText":"Like n follow&nbsp;","text":"Like n follow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863704569","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863454306,"gmtCreate":1632417320805,"gmtModify":1676530778428,"author":{"id":"3584955097359320","authorId":"3584955097359320","name":"FlareSpark","avatar":"https://static.tigerbbs.com/38942f5d417a8d645800903b08402b4e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3584955097359320","authorIdStr":"3584955097359320"},"htmlText":"Robot is the future","listText":"Robot is the future","text":"Robot is the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863454306","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863571392,"gmtCreate":1632408813816,"gmtModify":1676530776134,"author":{"id":"3571092559413416","authorId":"3571092559413416","name":"SSSG","avatar":"https://static.tigerbbs.com/8b6004ac9552e20472bc1792d3c17df6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571092559413416","authorIdStr":"3571092559413416"},"htmlText":"Thanks for the info","listText":"Thanks for the info","text":"Thanks for the info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863571392","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863237544,"gmtCreate":1632395871488,"gmtModify":1676530771928,"author":{"id":"3582026529372712","authorId":"3582026529372712","name":"ParrySKLow","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":1,"idStr":"3582026529372712","authorIdStr":"3582026529372712"},"htmlText":"Thanks for sharing&nbsp;","listText":"Thanks for sharing&nbsp;","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863237544","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5971060,"gmtCreate":1632396615632,"gmtModify":1663234331643,"authorId":3581579780416432,"author":{"id":3581579780416432,"idStr":"3581579780416432","authorId":3581579780416432,"name":"MachineGun","avatar":"https://static.tigerbbs.com/b2a731c3f57f68f2ebe7e41ebb718913","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":863237544,"type":1,"supId":0,"prevId":0,"content":"Yep","text":"Yep","html":"Yep"}],"langContent":"EN"},{"id":863239110,"gmtCreate":1632394992630,"gmtModify":1676530771562,"author":{"id":"3572916667219493","authorId":"3572916667219493","name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"idStr":"3572916667219493","authorIdStr":"3572916667219493"},"htmlText":"Hi ??&nbsp;","listText":"Hi ??&nbsp;","text":"Hi ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863239110","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":863201456,"gmtCreate":1632392638575,"gmtModify":1676530771127,"author":{"id":"3585352116267703","authorId":"3585352116267703","name":"ac1887","avatar":"https://static.tigerbbs.com/a4f5865f79452e7da123e88ff35959e5","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585352116267703","authorIdStr":"3585352116267703"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863201456","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5970626,"gmtCreate":1632393078146,"gmtModify":1663234328726,"authorId":3580354890331124,"author":{"id":3580354890331124,"idStr":"3580354890331124","authorId":3580354890331124,"name":"Foreverhuat","avatar":"https://static.tigerbbs.com/62fc823435d8b068f4f4c4263b83900a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":863201456,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"}],"langContent":"EN"},{"id":863678372,"gmtCreate":1632391379096,"gmtModify":1676530770757,"author":{"id":"3562150941808297","authorId":"3562150941808297","name":"KHYAP","avatar":"https://static.tigerbbs.com/134bef1736613cccadcb5091adcc32aa","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3562150941808297","authorIdStr":"3562150941808297"},"htmlText":"????????","listText":"????????","text":"????????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863678372","repostId":2169666103,"repostType":4,"repost":{"id":"2169666103","kind":"news","pubTimestamp":1632388163,"share":"https://ttm.financial/m/news/2169666103?lang=&edition=fundamental","pubTime":"2021-09-23 17:09","market":"us","language":"en","title":"Is Boston Scientific A Smart Long-Term Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2169666103","media":"Insider Monkey","summary":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Disco","content":"<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.</p>\n<p>In the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.</p>\n<p>Here is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:</p>\n<blockquote>\n \"Among our top contributors (includes) \n <b>Boston Scientific</b>. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/a8a578f975f6733b8ec762a397fde7fc\" tg-width=\"750\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">egyjanek/Shutterstock.com</p>\n<p>Based on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.</p>\n<p>Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&amp;P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.</p>\n<p>At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest growing industries right now, so we are checking out stock pitches like this&nbsp;<b>emerging lithium stock</b>. We go through lists like the 10&nbsp;best hydrogen fuel cell stocks&nbsp;to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on&nbsp;our homepage.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Boston Scientific A Smart Long-Term Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Boston Scientific A Smart Long-Term Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BSX":"波士顿科学"},"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-smart-long-050923561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169666103","content_text":"Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.28% was recorded by its Investor Class: APFDX, 10.27% by its Advisor Class: APDDX, and 10.35% by its Institutional Class: APHDX for the second quarter of 2021, all beating the MSCI All Country World Index that delivered a 7.39% return for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their top bets for 2021.\nIn the Q2 2021 investor letter of Artisan Partners, the fund mentioned Boston Scientific Corporation (NYSE: BSX) and discussed its stance on the firm. Boston Scientific Corporation is a Marlborough, Massachusetts-based medical devices manufacturer with a $63.5 billion market capitalization. BSX delivered a 24.14% return since the beginning of the year, while its 12-month returns are up by 18.32%. The stock closed at $43.36 per share on September 21, 2021.\nHere is what Artisan Partners has to say about Boston Scientific Corporation in its Q2 2021 investor letter:\n\n \"Among our top contributors (includes) \n Boston Scientific. Shares of Boston Scientific were volatile throughout most of 2020 as the pandemic drove significant drops in elective medical procedures, though our longer-term constructive view and belief elective medical procedures would bounce back post pandemic prompted us to add to our position. We have been rewarded with shares rebounding this year alongside a recovery in elective medical procedures. Longer-term, we believe the company’s investments in higher growth categories will drive revenue growth to the higher end of its peer group with rising margins.\"\n\negyjanek/Shutterstock.com\nBased on our calculations, Boston Scientific Corporation (NYSE: BSX) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. BSX was in 51 hedge fund portfolios at the end of the first half of 2021, compared to 44 funds in the previous quarter. Boston Scientific Corporation (NYSE: BSX) delivered a 1.92% return in the past 3 months.\nHedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.\nAt Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5970596,"gmtCreate":1632392643950,"gmtModify":1663234329632,"authorId":3585352116267703,"author":{"id":3585352116267703,"idStr":"3585352116267703","authorId":3585352116267703,"name":"ac1887","avatar":"https://static.tigerbbs.com/a4f5865f79452e7da123e88ff35959e5","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":863678372,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":96,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}